drugset / Trial / NCT06008028
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of "BR1015" and co-administration of "BR1015-1" and "BR1015-2" under fasting conditions in healthy volunteers
Timeline
- Start
- 2023-08-10
- Primary completion
- 2023-10-06
- Completion
- 2023-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR1015 | Unknown | — | — |
| Comparator | BR1015-1 | Unknown | — | — |
| Comparator | BR1015-2 | Unknown | — | — |